7th Annual Oncology Update: Advances and Controversies

Goal
The goal of this course is to provide information and discussion on new and innovative advances in oncology. This course is also designed to cover all of the disciplines that are involved in sarcoma, proton therapy, neuro-oncology, colorectal, melanoma, endocrine, urology, thoracic head and neck, breast, pancreas, and liver cancers.


Target Audience
This program will be of interest to surgical oncologists, medical oncologists, radiation oncologists, resident trainees, primary care physicians, advanced nurse practitioners and nurses involved in oncologic care.

Educational Objectives
After attending the conference, participants should be able to

* apply multimodality treatment to solid tumors including breast, melanoma, pancreatic, endocrine, rectal, hepatic, genitourinary, and sarcoma;
* define new treatment approaches to glioblastoma multiforme;
* identify new treatment approaches for esophageal and lung cancer;
* define the role of targeted agents in the treatment of colorectal cancer, sarcoma, renal cell carcinoma, and lung cancer;
* identify new radiation therapy techniques and applications.

Educational Methods
* Lectures
* Question-and-Answer Sessions
* Case Presentations
* Panel Discussions

Evaluation
A course evaluation form will provide participants with the opportunity to review each session and speaker, to identify future educational needs, and to comment on any perceived commercial bias in the presentations.

Accreditation/Credit Designation
The University of Texas M. D. Anderson Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The University of Texas M. D. Anderson Cancer Center designates this educational activity for a maximum of 21.50 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Conference Agenda
The conference will begin with registration, and a welcome reception from 4:00-5:00 p.m. on Saturday, January 13 followed by an evening session from 5:00-7:00 p.m. All other sessions will run from 7:00-9:00 a.m. and 4:30-7:00 p.m. on January 14-17.

Current Trends in Oncology Nursing

Educational Objectives
After attending the conference, participants should be able to

* describe and discuss future trends in oncology nursing to include molecular targeted therapies and symptom management strategies;